Your browser doesn't support javascript.
loading
CD47 Expression Defines Efficacy of Rituximab with CHOP in Non-Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL.
Bouwstra, Renée; He, Yuan; de Boer, Janneke; Kooistra, Hilde; Cendrowicz, Ewa; Fehrmann, Rudolf S N; Ammatuna, Emanuele; Zu Eulenburg, Christine; Nijland, Marcel; Huls, Gerwin; Bremer, Edwin; van Meerten, Tom.
Afiliación
  • Bouwstra R; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • He Y; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • de Boer J; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Kooistra H; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Cendrowicz E; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Fehrmann RSN; University of Groningen, University Medical Center Groningen, Department of Medical Oncology, Groningen, the Netherlands.
  • Ammatuna E; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Zu Eulenburg C; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
  • Nijland M; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Huls G; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands.
  • Bremer E; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands. t.van.meerten@umcg.nl e.bremer@umcg.nl.
  • van Meerten T; University of Groningen, University Medical Center Groningen, Department of Hematology, Groningen, the Netherlands. t.van.meerten@umcg.nl e.bremer@umcg.nl.
Cancer Immunol Res ; 7(10): 1663-1671, 2019 10.
Article en En | MEDLINE | ID: mdl-31409608

Texto completo: 1 Colección: 01-internacional Asunto principal: Fagocitosis / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Centro Germinal / Antígeno CD47 / Macrófagos Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Cancer Immunol Res Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Asunto principal: Fagocitosis / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células B Grandes Difuso / Centro Germinal / Antígeno CD47 / Macrófagos Tipo de estudio: Prognostic_studies Límite: Humans / Middle aged Idioma: En Revista: Cancer Immunol Res Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos